Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London
· Delayed Price · Currency is GBP · Price in GBX 181.00
-2.25 (-1.23%)
Apr 28, 2025, 8:35 AM BST
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 7.50 million as of April 25, 2025. Its market cap has decreased by -65.04% in one year.
Market Cap
7.50M
Enterprise Value
8.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
181.00
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has decreased from 10.68M to 7.50M, a decrease of -29.77%. That is a compound annual growth rate of -4.57%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.27B |
| GSK plc | 56.28B |
| Haleon | 34.06B |
| Smith & Nephew | 8.68B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.19B |
| HUTCHMED (China) | 1.95B |
| Oxford Nanopore Technologies | 1.14B |